HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Debabrata Saha Selected Research

N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamide

10/2009The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.
4/2009SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression.
5/2007SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor.
2/2006The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Debabrata Saha Research Topics

Disease

43Neoplasms (Cancer)
01/2022 - 08/2002
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 08/2003
9Prostatic Neoplasms (Prostate Cancer)
11/2019 - 04/2010
8Lung Neoplasms (Lung Cancer)
10/2020 - 01/2003
6Hypoxia (Hypoxemia)
01/2022 - 04/2009
5Carcinoma (Carcinomatosis)
01/2011 - 08/2003
4Glioblastoma (Glioblastoma Multiforme)
12/2021 - 05/2007
4Neoplasm Metastasis (Metastasis)
11/2019 - 07/2014
3Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2019
3Carcinogenesis
01/2019 - 10/2010
3Rectal Neoplasms (Rectal Cancer)
04/2011 - 07/2009
2Head and Neck Neoplasms (Head and Neck Cancer)
12/2021 - 01/2019
2Colonic Neoplasms (Colon Cancer)
01/2019 - 04/2011
2Chromosomal Instability (Chromosome Stability)
10/2016 - 04/2015
2Inflammation (Inflammations)
04/2013 - 08/2008
2Extranodal Extension
01/2011 - 01/2007
2Brain Neoplasms (Brain Tumor)
08/2003 - 01/2003
2Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2003 - 01/2003
1Glioma (Gliomas)
12/2021
1Mucositis
12/2021
1Adenocarcinoma
12/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
07/2014
1Chronic Hepatitis C
02/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2014
1Unilateral Breast Neoplasms
02/2014
1Pleural Effusion (Pleural Effusions)
04/2013
1Asthma (Bronchial Asthma)
04/2013
1Osteosarcoma (Osteogenic Sarcoma)
04/2013

Drug/Important Bio-Agent (IBA)

7DNA (Deoxyribonucleic Acid)IBA
01/2017 - 01/2008
6Proteins (Proteins, Gene)FDA Link
07/2014 - 08/2008
4Pharmaceutical PreparationsIBA
12/2021 - 09/2003
4Radiation-Sensitizing AgentsIBA
05/2015 - 09/2003
4N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
10/2009 - 02/2006
3Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2013
38- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA
10/2017 - 02/2015
3Biological ProductsIBA
01/2016 - 07/2010
3LuciferasesIBA
11/2014 - 04/2011
3ProstaglandinsIBA
02/2006 - 07/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2006 - 07/2002
2Oxygen (Dioxygen)IBA
01/2022 - 06/2017
2IonsIBA
01/2022 - 10/2010
2CrizotinibIBA
12/2021 - 03/2013
2Glutathione (Reduced Glutathione)IBA
12/2021 - 10/2020
2Polylactic Acid-Polyglycolic Acid CopolymerIBA
10/2017 - 05/2015
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
10/2016 - 05/2013
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
04/2015 - 12/2012
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
07/2014 - 04/2010
2TamoxifenFDA LinkGeneric
02/2014 - 07/2009
2epothilone B (EPO906)IBA
11/2010 - 09/2003
2Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2009 - 02/2006
22-aminothiazoleIBA
04/2009 - 05/2007
2NF-kappa B (NF-kB)IBA
04/2009 - 08/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2009 - 05/2007
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2003 - 01/2003
1ThioredoxinsIBA
12/2021
1Superoxides (Superoxide)IBA
12/2021
1Superoxide DismutaseIBA
12/2021
1CatalaseIBA
12/2021
1Neutralizing AntibodiesIBA
12/2021
1Buthionine SulfoximineIBA
12/2021
1avasopasem manganeseIBA
12/2021
1navitoclaxIBA
12/2021
1Auranofin (Ridaura)FDA Link
12/2021
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
12/2021
1DEAE-Dextran (Pulsar)IBA
01/2021
1Stimuli Responsive PolymersIBA
10/2020
1Polyurethanes (Polyurethane)IBA
10/2020
1DisulfidesIBA
10/2020
1Cisplatin (Platino)FDA LinkGeneric
10/2020
1Caveolin 1IBA
11/2019
1Dichlorodiphenyldichloroethane (DDD)IBA
11/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1Replication Protein AIBA
11/2017
1Cetuximab (Erbitux)FDA Link
11/2017
1carboxymethyl-chitosanIBA
10/2017
1Folic Acid (Vitamin M)FDA LinkGeneric
10/2017
1poly-N-isopropylacrylamideIBA
10/2017
1GemcitabineFDA Link
10/2017
1AndrogensIBA
12/2015
110- (2- hydroxypropyl)- 1,4,7- tetraazacyclododecane- 1,4,7- triacetic acidIBA
11/2015
1LigandsIBA
11/2015
1NitroimidazolesIBA
11/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2014
1cytolethal distending toxinIBA
07/2014
1Prostate-Specific Antigen (Semenogelase)IBA
07/2014
1Enhancer of Zeste Homolog 2 ProteinIBA
07/2014
1L 644711 (B-3(+))IBA
04/2013
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2013

Therapy/Procedure

20Radiotherapy
01/2022 - 01/2003
11Therapeutics
12/2021 - 01/2003
8Drug Therapy (Chemotherapy)
01/2022 - 01/2003
3Castration
11/2019 - 07/2014
1Immunotherapy
01/2021
1Injections
10/2020
1Segmental Mastectomy (Lumpectomy)
02/2014
1Aftercare (After-Treatment)
05/2013
1Image-Guided Radiotherapy
05/2013
1Combined Modality Therapy
05/2013
1Surgical Amputation (Amputations)
04/2013